List of articles with "Amgen"

IMDELLTRA® FDA Approval

2025-11-19 21:20:35

Amgen Thousand Oaks SCLC IMDELLTRA

Repatha® Lowers CV Event Risk

2025-11-08 15:23:27

None Amgen Repatha PCSK9 Inhibitor

Amgen Q3 2025 Results

2025-11-04 21:04:03

USA Amgen Thousand Oaks, California Repatha Otezla

Amgen's Dividend Announcement

2025-10-31 20:04:21

United States Dividend biotechnology Amgen Thousand Oaks

Repatha Phase 3 Results

2025-10-31 13:15:23

United States New Orleans Amgen Repatha Cardiovascular Trials

TEZSPIRE® Approval

2025-10-17 20:12:44

United States Amgen Thousand Oaks TEZSPIRE Allergy

AmgenNow Program

2025-10-06 13:56:06

USA Amgen Thousand Oaks Repatha AmgenNow

Repatha Trial Results

2025-10-02 14:05:13

USA Amgen Thousand Oaks Repatha VESALIUS-CV

Amgen’s $650M Expansion

2025-09-26 13:19:40

USA biopharmaceuticals Amgen Thousand Oaks USA manufacturing

Rocatinlimab Phase 3 Results

2025-09-09 00:11:50

USA Amgen Thousand Oaks Kyowa Kirin Rocatinlimab

Amgen's Major Investment

2025-09-02 13:48:03

United States Innovation Amgen Thousand Oaks Biopharmaceutical

Veeva and Amgen Collaborate

2025-08-28 19:38:15

USA Veeva Systems Barcelona Clinical Trials Amgen

Veeva and Amgen Collaboration

2025-08-28 17:26:52

USA Veeva Systems Barcelona Clinical Trials Amgen

Veeva and Amgen Collaboration

2025-08-28 17:25:44

USA Veeva Systems Barcelona Clinical Trial Amgen

Veeva and Amgen Partnership

2025-08-28 11:12:07

USA Veeva Systems Clinical Trials Amgen Pleasanton

Veeva and Amgen Collaboration

2025-08-28 11:11:47

Spain Veeva Systems Barcelona Clinical Trials Amgen

Repatha Approval Expanded

2025-08-25 13:19:25

United States Amgen Thousand Oaks Repatha LDL Cholesterol

Amgen Second Quarter 2025

2025-08-05 20:22:28

USA Amgen Thousand Oaks Repatha TAVNEOS

Amgen's Q3 2025 Dividend

2025-08-01 20:13:25

United States Dividend biotechnology Amgen Thousand Oaks

Amgen's Bemarituzumab Trial Results

2025-06-30 13:46:36

United States Amgen Thousand Oaks gastric cancer Bemarituzumab

Promising Results of MariTide

2025-06-23 18:37:05

United States California MariTide Amgen Obesity Treatment

Amgen's MariTide Data

2025-06-18 13:42:56

United States Chicago MariTide Amgen Type 2 Diabetes

Barry Sanders & Cholesterol

2025-06-13 13:16:48

USA Amgen Thousand Oaks Barry Sanders Cholesterol

IMDELLTRA® Breakthrough

2025-06-02 12:08:02

United States Amgen Thousand Oaks small cell lung cancer IMDELLTRA®

Amgen Q1 2025 Results

2025-05-01 20:19:13

None Amgen Repatha IMDELLTRA

Amgen Expands in Ohio

2025-04-25 16:59:36

United States Manufacturing Ohio Amgen Ohio Expansion

UPLIZNA Approved for IgG4-RD

2025-04-14 21:36:54

United States Las Vegas Amgen UPLIZNA IgG4-RD

IMDELLTRA® and SCLC

2025-04-11 13:15:34

USA Amgen Thousand Oaks SCLC IMDELLTRA

Rocatinlimab Success

2025-03-08 11:12:39

USA Amgen Thousand Oaks Kyowa Kirin Rocatinlimab

Rocatinlimab Phase 3 Insights

2025-03-08 11:12:22

USA Amgen Thousand Oaks Kyowa Kirin Rocatinlimab

Amgen Announces Dividend

2025-03-04 21:57:13

USA Dividend Amgen Thousand Oaks Stock Market

Tezspire® Efficacy in CRSwNP

2025-03-01 22:38:39

United States Amgen Thousand Oaks Tezspire® CRSwNP

Amgen at Citi's Summit

2025-02-14 21:14:58

USA Innovation oncology Amgen Thousand Oaks

Amgen's 2024 Financial Growth

2025-02-04 21:07:56

United States Amgen Thousand Oaks Repatha TEZSPIRE

BLINCYTO Approved

2025-01-31 11:56:46

USA Amgen Thousand Oaks BLINCYTO B-ALL

BLINCYTO Approval

2025-01-30 23:38:23

USA Amgen Thousand Oaks BLINCYTO B-ALL

BLINCYTO® Approval by EU

2025-01-30 22:21:40

USA Amgen Thousand Oaks BLINCYTO Acute Lymphoblastic Leukemia

BLINCYTO® Approved in EU

2025-01-30 18:19:29

USA Amgen Thousand Oaks Leukemia BLINCYTO

BLINCYTO® Approval

2025-01-30 17:58:42

None Amgen Thousand Oaks Leukemia BLINCYTO

BLINCYTO® Approval News

2025-01-30 17:15:18

None Amgen BLINCYTO Acute Lymphoblastic Leukemia Thousand Oaks, California

BLINCYTO® Approved

2025-01-30 12:26:24

USA Amgen Thousand Oaks Leukemia BLINCYTO

B-ALL Treatment Approved

2025-01-29 21:07:39

None Amgen BLINCYTO B-ALL

Recombination Map Unveiled

2025-01-22 16:11:32

Amgen Iceland Reykjavik deCODE genetics human genome

Human Genome Recombination

2025-01-22 16:10:19

Amgen Iceland Reykjavik deCODE genetics human genome

Amgen 2025 Dividend News

2024-12-10 21:43:09

Dividend Amgen Thousand Oaks NASDAQ:AMGN

BLINCYTO® Boosts Survival

2024-12-07 15:02:45

USA San Diego Amgen BLINCYTO Pediatric B-ALL

Amgen Expands in North Carolina

2024-12-05 15:20:01

United States North Carolina Amgen Biomanufacturing

Amgen at HealthCONx 2024

2024-11-29 21:43:24

USA biotechnology HealthCONx Amgen Thousand Oaks

Amgen's MariTide Breakthrough

2024-11-26 12:18:04

United States MariTide Amgen obesity Thousand Oaks